Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Impact of Growth Differentiating Factor (GDF) 15 in Sickle Cell Disease and Hereditary Spherocytosis

NCT01201135 is registered in ClinicalTrials.gov with Wolfson Medical Center as lead sponsor.

NCT NCT01201135
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01201135 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Impact of Growth Differentiating Factor (GDF) 15 in Sickle Cell Disease and Hereditary Spherocytosis
Lead sponsor
Wolfson Medical Center
Phase
Observational
Overall status
Unknown status
Start date
September 30, 2010
Completion date
September 30, 2011
Enrollment
80 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

congenital dyserythropoietic anemia type i, patients with thalassemia intermedia,